Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis

Sleep Medicine

Volumn 10, Issue 6, 2009, Pages 597-603

  Tang, Yueming ^a   Preuss, Fabian ^a,b   Turek, Fred W ^b   Jakate, Shriram ^a   Keshavarzian, Ali ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Colitis; Dextran sodium sulfate; Inflammatory bowel disease; Myeloperoxidase; Sleep deprivation; Sleep disturbance

Indexed keywords

DEXTRAN SULFATE; DRINKING WATER; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOPATHOLOGY; LOCOMOTION; MALE; MONITORING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SCORING SYSTEM; SLEEP DEPRIVATION; TISSUE INJURY; WEIGHT REDUCTION;

ACUTE DISEASE; ANIMALS; BODY WEIGHT; CHRONIC DISEASE; COLITIS; COLON; DEXTRAN SULFATE; DIARRHEA; DISEASE MODELS, ANIMAL; GASTROINTESTINAL HEMORRHAGE; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; PEROXIDASE; RECTAL DISEASES; SLEEP DEPRIVATION;

EID: 67349109359     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.12.009     Document Type: Article

References (35)

1. Keighley M.R., and Stockbrugger R.W. Inflammatory bowel disease. Aliment Pharmacol Ther 18 Suppl. 3 (2003) 66-70
2. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
3. Hart A., and Kamm M.A. Review article: mechanisms of initiation and perpetuation of gut inflammation by stress. Aliment Pharmacol Ther 16 (2002) 2017-2028
4. Mawdsley J.E., and Rampton D.S. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 54 (2005) 1481-1491
5. Mawdsley J.E., and Rampton D.S. The role of psychological stress in inflammatory bowel disease. Neuroimmunomodulation 13 (2006) 327-336
6. Mawdsley J.E., Macey M.G., Feakins R.M., Langmead L.., and Rampton D.S. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology 131 (2006) 410-419
7. Ranjbaran Z., Keefer L., Farhadi A., Stepanski E., Sedghi S., and Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol 22 (2007) 1748-1753
8. Ranjbaran Z., Keefer L., Stepanski E., Farhadi A., and Keshavarzian A. The relevance of sleep abnormalities to chronic inflammatory conditions. Inflamm Res 56 (2007) 51-57
9. Keefer L., Stepanski E.J., Ranjbaran Z., Benson L.M., and Keshavarzian A. An initial report of sleep disturbance in inactive inflammatory bowel disease. J Clin Sleep Med 2 (2006) 409-416
10. North C.S., Alpers D.H., Helzer J.E., Spitznagel E.L., and Clouse R.E. Do life events or depression exacerbate inflammatory bowel disease? A prospective study. Ann Intern Med 114 (1991) 381-386
11. Levenstein S., Prantera C., Varvo V., Scribano M.L., Andreoli A., Luzi C., et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 95 (2000) 1213-1220
12. Zisapel N. Sleep and sleep disturbances: biological basis and clinical implications. Cell Mol Life Sci 64 (2007) 1174-1186
13. Bryant P.A., Trinder J., and Curtis N. Sick and tired: does sleep have a vital role in the immune system?. Nat Rev Immunol 4 (2004) 457-467
14. Orr W.C., and Chen C.L. Sleep and the gastrointestinal tract. Neurol Clin 23 (2005) 1007-1024
15. Zimmerman J. Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms. Dig Dis Sci 48 (2003) 743-749
16. Kim Y., Laposky A.D., Bergmann B.M., and Turek F.W. Repeated sleep restriction in rats leads to homeostatic and allostatic responses during recovery sleep. Proc Natl Acad Sci USA 104 (2007) 10697-10702
17. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98 (1990) 694-702
18. Abdelbaqi M., Chidlow J.H., Matthews K.M., Pavlick K.P., Barlow S.C., Linscott A.J., et al. Regulation of dextran sodium sulfate induced colitis by leukocyte beta 2 integrins. Lab Invest 86 (2006) 380-390
19. Van der Sluis M., De Koning B.A., De Bruijn A.C., Velcich A., Meijerink J.P., Van Goudoever J.B., et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131 (2006) 117-129
20. Rath H.C., Herfarth H.H., Ikeda J.S., Grenther W.B., Hamm Jr. T.E., Balish E., et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 98 (1996) 945-953
21. Bradley P.P., Priebat D.A., Christensen R.D., and Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78 (1982) 206-209
22. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
23. Pizarro T.T., Arseneau K.O., Bamias G., and Cominelli F. Mouse models for the study of Crohn's disease. Trends Mol Med 9 (2003) 218-222
24. Elson C.O., Sartor R.B., Tennyson G.S., and Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology 109 (1995) 1344-1367
25. Costa F., Mumolo M.G., Ceccarelli L., Bellini M., Romano M.R., and Sterpi C. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 54 (2005) 364-368
26. Bernstein C.N., Walker J.R., and Graff L.A. On studying the connection between stress and IBD. Am J Gastroenterol 101 (2006) 782-785
27. Sperber A.D., and Tarasiuk A. Disrupted sleep in patients with IBS-a wake-up call for further research?. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 412-413
28. van Dieren J.M., Kuipers E.J., Samsom J.N., Nieuwenhuis E.E., and van der Woude C.J. Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD. Inflamm Bowel Dis 12 (2006) 311-327
29. Xavier R.J., and Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007) 427-434
30. Vgontzas A.N., Bixler E.O., Lin H.M., Prolo P., Trakada G., and Chrousos G.P. IL-6 and its circadian secretion in humans. Neuroimmunomodulation 12 (2005) 131-140
31. Opp M.R. Cytokines and sleep. Sleep Med Rev 9 (2005) 355-364
32. Uthgenannt D., Schoolmann D., Pietrowsky R., Fehm H.L., and Born J. Effects of sleep on the production of cytokines in humans. Psychosom Med 57 (1995) 97-104
33. Irwin M., Clark C., Kennedy B., Christian Gillin J., and Ziegler M. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain Behav Immun 17 (2003) 365-372
34. Savard J., Laroche L., Simard S., Ivers H., Morin C.M., et al. Chronic insomnia and immune functioning. Psychosom Med 65 (2003) 211-221
35. Sakami S., Ishikawa T., Kawakami N., Haratani T., Fukui A., Kobayashi F., et al. Coemergence of insomnia and a shift in the Th1/Th2 balance toward Th2 dominance. Neuroimmunomodulation 10 (2002) 337-343